Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccines based on mutant CALR and JAK2 and their uses

Vaccines based on mutant CALR and JAK2 and their uses

US Patent 12018289 · Granted Jun 25, 2024

Estimated economic value: $184,084,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alphavirus-based replicons for administration of biotherapeutics2025
EGFR and C-met fibronectin type III domain binding molecules2025
Prostate neoantigens and their uses2025
Prostate neoantigens and their uses2025
Neoantigen peptide mimics2025
Neoantigen peptide mimics2025
Anti-Vβ17/anti-CD123 bispecific antibodies2025
CD137 binding fibronectin type III domains2025
Anti-VISTA antibodies and fragments2025
GPRC5D chimeric antigen receptors and cells expressing the same2024
Potent and short promoter for expression of heterologous genes2024
Compositions and methods for immune cell modulation in adoptive immunotherapies2024